What is BFRI's dilution risk score?

BFRI has a latest available DilutionScore record of 62/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for BFRI, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for BFRI?

DilutionWatch tracks 25 SEC filing types for BFRI including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect BFRI shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For BFRI, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for BFRI tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for BFRI. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

BFRI Dilution Risk Score: 62/100 (HIGH)

Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

85

📊 Float Risk

42

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 47%

🔄 Reverse Split model est. 70%

• 50-day avg $0.97 below $1 exchange minimum

• Only 5 months cash — financial pressure

💰 Capital Raise model 35%

• Low cash runway: 5 months remaining

📉 Score Deterioration model 10%

• Score in HIGH risk zone (62/100)

🔔 Track BFRI — Get forecast alerts →

Market Data

Market Cap$11.34M

Shares Outstanding14.85M

Float8.06M

Cash$4.66M

Debt$296.0K

Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

Field	Current Value	Basis
DilutionScore	62/100	DilutionWatch score record
Shares Outstanding	14.85M	Verified float table or market cache
Public Float	8.06M	Verified float table or market cache
Market Cap	$11.34M	Market data cache
Cash Runway	5.0 months	DilutionWatch score inputs
Shelf Capacity	None in current score inputs	SEC-derived dilution fields
ATM Capacity	None in current score inputs	SEC-derived dilution fields
Outstanding Warrants	None in current score inputs	SEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 4.6% shares (2026Q1 vs prior)

12 institutional holders · 2.44M shares

#1 Rosalind Advisors, Inc. 1.16M shares

#2 AIGH Capital Management LLC 915.2K shares

#3 GEODE CAPITAL MANAGEMENT, LLC 109.3K shares

+ 9 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest255.3K

Days to Cover1.0

% of Float3.2%

FINRA data as of Aug 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-06-30

xbrl XBRL WARRANT 2025-12-31

4 INSIDER TRANSACTION 2026-03-06

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual BFRI Dilution Snapshot

Biofrontera Inc. (BFRI) has a DilutionScore of 62/100, rated High dilution risk. Score date: September 12, 2026.

Recent SEC activity tracked for BFRI: xbrl on 2026-06-30; 4 on 2026-03-06; 4 on 2026-03-06.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.